Biocon Ltd buy melinda
Start price
07.09.17
/
50%
?2.26
Target price
30.11.17
€3.25
Performance (%)
23.78%
End price
30.11.17
€2.80
Summary
This prediction ended on 30.11.17 with a price of €2.80. The prediction had a final performance of 23.78%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Biocon Ltd | - | - | - | - |
iShares Core DAX® | -0.268% | 5.471% | 14.271% | 19.027% |
iShares Nasdaq 100 | 1.854% | 7.851% | 35.426% | 58.415% |
iShares Nikkei 225® | 0.284% | 1.729% | 9.943% | 7.045% |
iShares S&P 500 | 1.178% | 5.269% | 27.989% | 49.400% |
Comments by melinda for this prediction
In the thread Biocon Ltd diskutieren
Biotechnologie und Medizintechnik
Biocon sagt die Insuline in Malaysia ein EU - GMP - Konformitätszertifikat erhalten
7. September (Reuters) - Biocon Ltd Biocon Insulin Institutionen in Malaysia erhalten eine EU - GMP - Konformitätsbescheinigung
(Vom Mitglied beendet)